Skip to content

Transumbilical Versus Lateral Transabdominal Removal of Benign Adnexal Masses Via Laparoscopy

Transumbilical Versus Lateral Transabdominal Removal of Benign Adnexal Masses Via Laparoscopy, a Randomized Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02704663
Enrollment
42
Registered
2016-03-10
Start date
2014-11-30
Completion date
2016-05-31
Last updated
2016-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Keywords

adnexal mass, laparoscopy, removal route, postoperative pain

Brief summary

In cases of benign adnexal mass laparoscopic surgery, women were randomized to two groups: transumbilical vs. transabdominal removal. Need for pain medication, postoperative pain and patients´ satisfaction were assessed between the groups, as well as surgeons´ opinions and costs.

Detailed description

Women assigned to laparoscopic surgery for removal of a benign adnexal mass were randomly divided into two groups as regards surgery: a transumbilical (TU) group (n=21) and a transabdominal (TA) group (n=21). General anesthesia and use of local anesthetics were standardized. Visual analog scale (VAS) scores for pain and side effects (nausea/vomiting) and the amount of postoperative analgesic used were recorded for 24 hours. Investigators also investigated the expenses related to endobags and trocars. Further, peri- and postoperative complications were recorded. Investigators inquired about patient satisfaction as well as the surgeons' opinions of the alternative methods available.

Interventions

PROCEDURETransumbilical removal of specimen via laparoscopy

Transumbilical removal of a benign adnexal mass from the abdominal cavity in laparoscopy

PROCEDURELateral transabdominal removal of specimen via laparoscopy

Lateral transabdominal removal of a benign adnexal mass from the abdominal cavity in laparoscopy

Sponsors

Helsinki University Central Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* The criteria for inclusion were scheduled laparoscopy for oophorectomy, salpingo-oophorectomy or cyst enucleation.

Exclusion criteria

* The

Design outcomes

Primary

MeasureTime frameDescription
The use of analgesics for postoperative painChange in 24 hours after surgeryThe total amount of analgesics used measured by use of Oxycodone (mg)

Secondary

MeasureTime frameDescription
NauseaChange in 24 hours after surgeryNausea after the procedure: Visual Analog Score (VAS) for nausea, to measure quality of nausea. 10-point VAS score for nausea \[(0-10), 0 indicating no nausea and 10 indicating unbearable nausea. at 1, 3, 6, 12 and 24 h (hour) after surgery. (Units on a Scale; 0-10)
VomitingChange in 24 hours after surgeryVomiting after the procedure: Visual Analog Score (VAS) for vomiting to measure quality of vomiting. 10-point VAS score for vomiting \[(0-10), 0 indicating no vomiting and 10 indicating unbearable vomiting\] at 1, 3, 6, 12 and 24 h (hour) after surgery. (Units on a Scale; 0-10)
Length of hospital stay in hoursUp to one weekLength of hospital stay measured from the end of the operation until discharge (hours)
Quality of lifeAt baseline and 6 months after the surgeryA questionnaire six months after operation concerning wellbeing outcome after six months (% of respondents in the group)
ComplicationsThe first six months after the surgical interventionFrequency of complications. Values are given as n (%) and eventual complications are specified
CostsDuring the surgeryCalculating the comparative direct costs of both techniques. The cost of equipment used in the surgical intervention. (euros)
Surgeon perception of both techniquesAfter one month after the operationA questionnaire one month after operation of opinion of surgeons on preferred route of specimen removal (% of respondents in the group)
Length of need of postoperative pain medicationChange in one month after surgeryA questionnaire of pain medication needed postoperatively. (Days)
Postoperative pain scoresChange in 24 hours after surgeryVisual Analog Score (VAS) for pain to measure quality of pain. 10-point VAS score for pain \[(0-10), 0 indicating no pain and 10 indicating unbearable pain\] at 1, 3, 6, 12 and 24 h (hour) after surgery (Units on a Scale; 0-10)
Cosmetic outcomeAt baseline and 6 months after the surgeryA questionnaire six months after operation concerning cosmetic outcome after six months (% of respondents in the group)

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026